Overview
INF2 (Inverted Formin 2) is a protein-coding gene located on chromosome 14q12 that encodes a unique member of the formin family of actin-regulating proteins. The INF2 protein is approximately 1,123 amino acids in length and is characterized by an inverted domain architecture compared to classical formins, featuring an N-terminal formin homology 2 (FH2) domain and a C-terminal formin homology 3 (FH3) domain. This protein exists as multiple isoforms generated through alternative splicing and subcellular localization signals, with variants localizing to the endoplasmic reticulum (ER) membrane, mitochondrial outer membrane, and cytoplasm. INF2 belongs to the larger family of formins, which are conserved regulators of actin polymerization and cytoskeletal dynamics across eukaryotic organisms.
Function and Biology
INF2 functions as a nucleation factor that promotes the formation of linear actin filaments, a process essential for maintaining cellular architecture and enabling diverse biological processes. The protein nucleates actin polymerization through its FH2 domain, which binds actin monomers and facilitates their assembly into dynamic filaments. Unlike conventional formins that promote actin polymerization in the forward direction along filament barbed ends, INF2 exhibits bidirectional nucleation capacity and can also sever existing actin filaments, allowing for rapid remodeling of the cytoskeletal network.
...Overview
INF2 (Inverted Formin 2) is a protein-coding gene located on chromosome 14q12 that encodes a unique member of the formin family of actin-regulating proteins. The INF2 protein is approximately 1,123 amino acids in length and is characterized by an inverted domain architecture compared to classical formins, featuring an N-terminal formin homology 2 (FH2) domain and a C-terminal formin homology 3 (FH3) domain. This protein exists as multiple isoforms generated through alternative splicing and subcellular localization signals, with variants localizing to the endoplasmic reticulum (ER) membrane, mitochondrial outer membrane, and cytoplasm. INF2 belongs to the larger family of formins, which are conserved regulators of actin polymerization and cytoskeletal dynamics across eukaryotic organisms.
Function and Biology
INF2 functions as a nucleation factor that promotes the formation of linear actin filaments, a process essential for maintaining cellular architecture and enabling diverse biological processes. The protein nucleates actin polymerization through its FH2 domain, which binds actin monomers and facilitates their assembly into dynamic filaments. Unlike conventional formins that promote actin polymerization in the forward direction along filament barbed ends, INF2 exhibits bidirectional nucleation capacity and can also sever existing actin filaments, allowing for rapid remodeling of the cytoskeletal network.
The subcellular localization of INF2 isoforms determines their specific functions. The ER-targeted isoforms contain an N-terminal signal sequence and interact with the ER membrane system, where they regulate actin dynamics at the ER-plasma membrane interface and influence ER morphology. Mitochondrial isoforms of INF2, containing mitochondrial targeting sequences, localize to the outer mitochondrial membrane and regulate actin polymerization in the perimembrane space surrounding mitochondria. This spatial organization allows INF2 to coordinate cytoskeletal dynamics with organellar structure and function.
INF2 activity is regulated by several mechanisms including interaction with phosphatidic acid and other phospholipids, binding to regulatory proteins such as Rho GTPases, and post-translational modifications including phosphorylation. The protein responds to calcium signaling and stress conditions, making it responsive to cellular pathological states.
Role in Neurodegeneration
INF2 mutations have been identified as causative agents in Charcot-Marie-Tooth disease type 2N (CMT2N), an autosomal dominant peripheral neuropathy characterized by progressive degeneration of peripheral sensory and motor neurons. More than 30 pathogenic variants in INF2 have been documented in CMT2N patients, including frameshift mutations, missense mutations, and nonsense mutations distributed throughout the gene. The majority of CMT2N-associated mutations cluster in the FH2 and FH3 domains, suggesting that disrupted actin nucleation capacity underlies disease pathogenesis.
The relationship between INF2 dysfunction and neuronal degeneration likely stems from compromised cytoskeletal dynamics in axons and synaptic terminals, where stable and dynamic actin networks are critical for maintaining axonal integrity, enabling axonal transport, and supporting synaptic plasticity. Neurons are particularly vulnerable to actin regulation defects due to their extreme morphological polarization and dependence on precise cytoskeletal organization.
Molecular Mechanisms
INF2 mutations in CMT2N patients impair actin nucleation capacity through multiple mechanisms. Some mutations disrupt the structural integrity of the FH2 domain, directly impairing actin monomer binding or filament nucleation. Other mutations alter protein stability or subcellular localization, preventing proper targeting to ER or mitochondrial membranes where INF2 normally functions. Gain-of-function mechanisms have also been proposed, wherein mutant INF2 exhibits excessive actin nucleation or severing activity, leading to pathological actin remodeling.
Mitochondrial dysfunction has emerged as a potential contributor to INF2-related neurodegeneration, as ER and mitochondrial isoforms regulate metabolic organelle integrity and energy production. Dysregulated mitochondrial actin dynamics may compromise ATP synthesis and increase oxidative stress in vulnerable neurons.
Clinical and Research Significance
INF2-related CMT2N represents an important genetic form of peripheral neuropathy with variable clinical severity and age of onset. Identification of INF2 mutations has enabled genetic diagnosis and counseling in affected families. Research on INF2 has illuminated the critical importance of proper actin regulation in maintaining axonal integrity and neuronal health, with implications for understanding other neurodegenerative diseases characterized by axonopathy.
Related genes and pathways include other formin family members (mDia1, mDia2, DIAPH3), Rho GTPase signaling regulators, actin-binding proteins (profilin, cofilin), and genes associated with CMT2 subtypes (MFN2, GDAP1, HSPB1).